bpc-157 schweiz BPC-157 10mg - Vita Peptides

Preclinical and clinical studies demonstrate that co-administration of these peptides achieves superior reductions in bodyweight, appetite, and fasting glucose than either agent aloneachieving up to a 17% reduction in bodyweight in non-diabetic individuals and a 15.6% reduction in patients with type 2 diabetes over 2032 weeks

The timeline varies depending on the individual, but studies show some patients may lose around 20 pounds within a few months when using tirzepatide as part of a medically supervised weight management plan

Peer-reviewed studies relevant to Dihexa are listed in the Citations tab on this product page

Every peptide plan is developed and overseen by a medical provider